Should we expect a wave of type 1 diabetes following SARS-CoV-2 pandemic?

Montefusco, Laura; Bolla, Andrea Mario; Fiorina, Paolo

Montefusco, Laura; Bolla, Andrea Mario; Fiorina, Paolo.

Montefusco L; Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.
Bolla AM; Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.
Fiorina P; Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.

Diabetes Metab Res Rev ; 38(4): e3529, 2022 05.

Article in English | MEDLINE | ID: covidwho-1819352

Subject(s)

COVID-19; Diabetes Mellitus, Type 1; COVID-19/epidemiology; Diabetes Mellitus, Type 1/epidemiology; Humans; Pandemics; SARS-CoV-2

Keywords

COVID-19; beta-cell damage; pancreatic autoimmunity; type 1 diabetes

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Diabetes Metab Res Rev Journal subject: Endocrinology / Metabolism Year: 2022 Document Type: Article Affiliation country: Dmrr.3529

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google